Found: 20
Select item for more details and to access through your institution.
First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1774, doi. 10.1007/s10637-020-00928-z
- By:
- Publication type:
- Article
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 674, doi. 10.1007/s10637-018-0674-x
- By:
- Publication type:
- Article
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41618-7
- By:
- Publication type:
- Article
Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 118, doi. 10.3390/ijms24010118
- By:
- Publication type:
- Article
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 9, p. 1827, doi. 10.1002/1878-0261.12547
- By:
- Publication type:
- Article
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1263, doi. 10.1002/1878-0261.12099
- By:
- Publication type:
- Article
Prognostic Nomogram and Patterns of Use of FOLFIRI‐Aflibercept in Advanced Colorectal Cancer: A Real‐World Data Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e687, doi. 10.1634/theoncologist.2018-0824
- By:
- Publication type:
- Article
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 375, doi. 10.1634/theoncologist.2016-0133
- By:
- Publication type:
- Article
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992974
- By:
- Publication type:
- Article
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992974
- By:
- Publication type:
- Article
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920936089
- By:
- Publication type:
- Article
Optimizing Administration of Third-Line Treatment in Metastatic Colorectal Cancer: Q&A.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 16
- By:
- Publication type:
- Article
Recent Study Data in Third-Line Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, p. 13
- By:
- Publication type:
- Article
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4514, doi. 10.3390/cancers13184514
- By:
- Publication type:
- Article
Clinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2254221, doi. 10.1001/jamanetworkopen.2022.54221
- By:
- Publication type:
- Article